Roger D. Tung
2020
In 2020, Roger D. Tung earned a total compensation of $3M as President and Chief Executive Officer at Concert Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,082 |
|---|---|
| Option Awards | $1,011,657 |
| Salary | $581,967 |
| Stock Awards | $1,098,957 |
| Other | $12,114 |
| Total | $3,024,777 |
Tung received $1.1M in stock awards, accounting for 36% of the total pay in 2020.
Tung also received $320.1K in non-equity incentive plan, $1M in option awards, $582K in salary and $12.1K in other compensation.
Rankings
In 2020, Roger D. Tung's compensation ranked 3,818th out of 13,090 executives tracked by ExecPay. In other words, Tung earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,818 out of 13,090 | 71st |
Division Manufacturing | 1,517 out of 5,621 | 73rd |
Major group Chemicals And Allied Products | 569 out of 2,254 | 75th |
Industry group Drugs | 489 out of 1,954 | 75th |
Industry Pharmaceutical Preparations | 369 out of 1,459 | 75th |
Source: SEC filing on April 27, 2021.
Tung's colleagues
We found two more compensation records of executives who worked with Roger D. Tung at Concert Pharmaceuticals in 2020.
News
Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
April 26, 2022
Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
April 27, 2021
Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
April 28, 2020
Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
April 29, 2019